PTF1A and glucose measurement: In humans, nonsense mutations in Ptf1a lead to exocrine pancreatic agenesis and neonatal diabetes (Krapp et al., 1998), while reduced Ptf1a dosage results in pancreatic hypoplasia, insufficient insulin secretion and glucose intolerance in mice (Fukuda et al., 2008).